Cargando…

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis

BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia (AE-UCIIP) remain to be elucidated. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Enomoto, Noriyuki, Naoi, Hyogo, Aono, Yuya, Katsumata, Mineo, Horiike, Yasuoki, Yasui, Hideki, Karayama, Masato, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Fujisawa, Tomoyuki, Inui, Naoki, Nakamura, Yutaro, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328360/
https://www.ncbi.nlm.nih.gov/pubmed/32600180
http://dx.doi.org/10.1177/1753466620935774
_version_ 1783552720596107264
author Enomoto, Noriyuki
Naoi, Hyogo
Aono, Yuya
Katsumata, Mineo
Horiike, Yasuoki
Yasui, Hideki
Karayama, Masato
Hozumi, Hironao
Suzuki, Yuzo
Furuhashi, Kazuki
Fujisawa, Tomoyuki
Inui, Naoki
Nakamura, Yutaro
Suda, Takafumi
author_facet Enomoto, Noriyuki
Naoi, Hyogo
Aono, Yuya
Katsumata, Mineo
Horiike, Yasuoki
Yasui, Hideki
Karayama, Masato
Hozumi, Hironao
Suzuki, Yuzo
Furuhashi, Kazuki
Fujisawa, Tomoyuki
Inui, Naoki
Nakamura, Yutaro
Suda, Takafumi
author_sort Enomoto, Noriyuki
collection PubMed
description BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia (AE-UCIIP) remain to be elucidated. The aim of this study was to clarify the clinical features and prognosis of AE-UCIIP compared with those of AE-IPF. METHODS: In 187 patients with UCIIP or IPF, 64 patients with AE-UCIIP or AE-IPF, who were diagnosed and treated at our hospital, were retrospectively evaluated. RESULTS: A total of 24 patients with AE-UCIIP were significantly older (p = 0.011), included more women (p < 0.001) and never-smokers (p < 0.001), and showed fewer lung lesions on high-resolution computed tomography (p = 0.006) than 40 patients with AE-IPF. Incidence of AE-UCIIP was 10.29%/year and was significantly higher than in AE-IPF (Gray’s test, p = 0.008). Prognosis of AE-UCIIP was as poor as that of AE-IPF (log-rank, p = 0.681). Percent-predicted forced vital capacity (%FVC) [hazard ratio (HR) 0.934, p = 0.045], and GAP stage within 12 months before AE (HR 3.530, p = 0.023), and partial pressure arterial oxygen/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio at AE (HR 0.998, p = 0.016) were significant prognostic factors. Finally, commencement of long-duration (⩾12 h) direct hemoperfusion with a polymyxin B-immobilised fibre column (PMX-DHP) within 2 days after admission significantly improved survival (log-rank, p = 0.038) and was a significant prognostic factor (HR 0.175, p = 0.0039) in AE-UCIIP. Long-duration PMX-DHP showed favourable treatment effects even in the combined group of patients with AE-UCIIP or AE-IPF (log-rank p = 0.002; HR 0.328, p = 0.006). CONCLUSIONS: Patients with AE-UCIIP were older and included more women and never-smokers than those with AE-IPF. Prognosis of AE-UCIIP was as poor as that of AE-IPF. The reviews of this paper are available via the supplemental material section.
format Online
Article
Text
id pubmed-7328360
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-73283602020-07-09 Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis Enomoto, Noriyuki Naoi, Hyogo Aono, Yuya Katsumata, Mineo Horiike, Yasuoki Yasui, Hideki Karayama, Masato Hozumi, Hironao Suzuki, Yuzo Furuhashi, Kazuki Fujisawa, Tomoyuki Inui, Naoki Nakamura, Yutaro Suda, Takafumi Ther Adv Respir Dis Original Research BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia (AE-UCIIP) remain to be elucidated. The aim of this study was to clarify the clinical features and prognosis of AE-UCIIP compared with those of AE-IPF. METHODS: In 187 patients with UCIIP or IPF, 64 patients with AE-UCIIP or AE-IPF, who were diagnosed and treated at our hospital, were retrospectively evaluated. RESULTS: A total of 24 patients with AE-UCIIP were significantly older (p = 0.011), included more women (p < 0.001) and never-smokers (p < 0.001), and showed fewer lung lesions on high-resolution computed tomography (p = 0.006) than 40 patients with AE-IPF. Incidence of AE-UCIIP was 10.29%/year and was significantly higher than in AE-IPF (Gray’s test, p = 0.008). Prognosis of AE-UCIIP was as poor as that of AE-IPF (log-rank, p = 0.681). Percent-predicted forced vital capacity (%FVC) [hazard ratio (HR) 0.934, p = 0.045], and GAP stage within 12 months before AE (HR 3.530, p = 0.023), and partial pressure arterial oxygen/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio at AE (HR 0.998, p = 0.016) were significant prognostic factors. Finally, commencement of long-duration (⩾12 h) direct hemoperfusion with a polymyxin B-immobilised fibre column (PMX-DHP) within 2 days after admission significantly improved survival (log-rank, p = 0.038) and was a significant prognostic factor (HR 0.175, p = 0.0039) in AE-UCIIP. Long-duration PMX-DHP showed favourable treatment effects even in the combined group of patients with AE-UCIIP or AE-IPF (log-rank p = 0.002; HR 0.328, p = 0.006). CONCLUSIONS: Patients with AE-UCIIP were older and included more women and never-smokers than those with AE-IPF. Prognosis of AE-UCIIP was as poor as that of AE-IPF. The reviews of this paper are available via the supplemental material section. SAGE Publications 2020-06-29 /pmc/articles/PMC7328360/ /pubmed/32600180 http://dx.doi.org/10.1177/1753466620935774 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Enomoto, Noriyuki
Naoi, Hyogo
Aono, Yuya
Katsumata, Mineo
Horiike, Yasuoki
Yasui, Hideki
Karayama, Masato
Hozumi, Hironao
Suzuki, Yuzo
Furuhashi, Kazuki
Fujisawa, Tomoyuki
Inui, Naoki
Nakamura, Yutaro
Suda, Takafumi
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
title Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
title_full Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
title_fullStr Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
title_full_unstemmed Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
title_short Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
title_sort acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328360/
https://www.ncbi.nlm.nih.gov/pubmed/32600180
http://dx.doi.org/10.1177/1753466620935774
work_keys_str_mv AT enomotonoriyuki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT naoihyogo acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT aonoyuya acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT katsumatamineo acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT horiikeyasuoki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT yasuihideki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT karayamamasato acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT hozumihironao acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT suzukiyuzo acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT furuhashikazuki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT fujisawatomoyuki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT inuinaoki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT nakamurayutaro acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis
AT sudatakafumi acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis